Clinical Trials

48 enrolled

Gynecologic

Clear Cell Tumor

NCT06344715 2024-04-03

Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.

78 enrolled

Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT05311618 2024-04-01

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

71 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06320353 2024-03-20

Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma

Phase 3 Unknown

266 enrolled

Melanoma, Neoplasms

NCT04249739 2024-03-13

Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive

93 enrolled

Stomach Neoplasms

NCT05368207 2024-03-13

Pemb-HT

Phase NA Unknown

1 enrolled

Gynecologic

Ovarian Neoplasms, Carcinoma, Small Cell

NCT05872867 2024-03-12

MK-3475-E90

GastrointestinalHead & NeckThoracic

54 enrolled

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06307093 2024-03-12

Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

DermatologicHead & NeckThoracic

90 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Lung Neoplasms, Melanoma, Neoplasms

NCT05567588 2024-02-01

Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer

66 enrolled

Clear-cell metastatic renal cell carcinoma

NCT03789097 2024-01-30

Vaccination With Flt3L, Radiation, and Poly-ICLC

BreastHead & NeckLymphoid

56 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Lymphoma, Lymphoma, Non-Hodgkin

NCT03532737 2024-01-23

Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer

50 enrolled

Head & Neck

Head and Neck Neoplasms

NCT04224480 2024-01-19

Longitudinal Immune-phenotyping of HCC Following MK-3475

8 enrolled

Phase EARLY_PHASE1 Unknown

Carcinoma, Hepatocellular

NCT06204614 2024-01-12

Drug Screening Using IMD in Bladder Cancer

18 enrolled

Muscle Invasive Bladder Urothelial Carcinoma

NCT06196554 2024-01-09

Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs

40 enrolled

Stomach Neoplasms

NCT02557321 2023-11-21

PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma

50 enrolled

Melanoma

NCT04294576 2023-11-09

FIH

92 enrolled

Other solid neoplasm

Locally Advanced/Metastatic Solid Tumors

NCT03458455 2023-11-01

TREATMENT

200 enrolled

CNS

Brain Neoplasms

NCT06100796 2023-10-25

NSCLC

60 enrolled

Diabetes Mellitus

NCT04546074 2023-10-03

Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma

22 enrolled

Melanoma

NCT05174832 2023-09-28

Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients

136 enrolled

Breast

Triple Negative Breast Neoplasms

NCT05986331 2023-09-21

Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma

Phase 3 Unknown

366 enrolled

Melanoma

NCT05418660 2023-09-18

I-STOP

300 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06031597 2023-09-13

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Phase 3 Unknown

105 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Radiation Pneumonitis

NCT05296772 2023-09-06

Phase 1 First-in-human Study of JS014

60 enrolled

Lymphoid

Lymphoma, Neoplasms, Neoplasms, Experimental

NCT02858921 2023-08-30

Neo Trio

60 enrolled

Melanoma, Neoplasms

NCT05578664 2023-08-30

PE-PE

81 enrolled

Oligometastatic Renal Cell Carcinoma

NCT03331731 2023-08-21

PLIMATH

27 enrolled

Lymphoid

Hodgkin Disease

NCT06000358 2023-08-21

LUCACRIMUNO

Phase NA Unknown

120 enrolled

Thoracic

Lung Neoplasms, Neoplasms

NCT04262687 2023-08-18

POCHI

55 enrolled

Colorectal Cancer Metastatic

NCT05739006 2023-08-02

Clinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced Malignancies

131 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT05708950 2023-07-13

A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)